Role of Hippocampal and Prefrontal Cortical Cholinergic Transmission in Combination Therapy Valproate and Cannabidiol in Memory Consolidation in Rats: Involvement of CREB- BDNF Signaling Pathways

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 2024 Jan 8

PMID 38189934

Authors

Navid Fatahi

Majid Jafari-Sabet

Gelareh Vahabzadeh

Alireza Komaki

Affiliations

Soon will be listed here.

Abstract

Purpose: Cognitive disorders are associated with valproate and drugs used to treat neuropsychological diseases. Cannabidiol (CBD) has beneficial effects on cognitive function. This study examined the effects of co-administration of CBD and valproate on memory consolidation, cholinergic transmission, and cyclic AMP response element-binding protein (CREB)-brain-derived neurotrophic factor (BDNF) signaling pathway in the prefrontal cortex (PFC) and hippocampus (HPC).

Methods: One-trial, step-through inhibitory test was used to evaluate memory consolidation in rats. The intra-CA1 injection of physostigmine and atropine was performed to assess the role of cholinergic transmission in this co-administration. Phosphorylated CREB (p-CREB)/CREB ratio and BDNF levels in the PFC and HPC were evaluated.

Results: Post-training intraperitoneal (i.p.) valproate injection reduced memory consolidation; however, post-training co-administration of CBD with valproate ameliorated memory impairment induced by valproate. Post-training intra-CA1 injection of physostigmine at the ineffective doses in memory consolidation (0.5 and 1 µg/rat), plus injection of 10 mg/kg of CBD as an ineffective dose, improved memory loss induced by valproate, which was associated with BDNF and p-CREB level enhancement in the PFC and HPC. Conversely, post-training intra-CA1 injection of ineffective doses of atropine (1 and 2 µg/rat) reduced the positive effects of injection of CBD at a dose of 20 mg/kg on valproate-induced memory loss associated with BDNF and p-CREB level reduction in the PFC and HPC.

Conclusion: The results indicated a beneficial interplay between valproate and CBD in the process of memory consolidation, which probably creates this interaction through the BDNF-CREB signaling pathways in the cholinergic transmission of the PFC and HPC regions.

References

Abu-Sawwa R, Scutt B, Park Y . Emerging Use of Epidiolex (Cannabidiol) in Epilepsy. J Pediatr Pharmacol Ther. 2020; 25(6):485-499. PMC: 7439947. DOI: 10.5863/1551-6776-25.6.485. View

Amidfar M, de Oliveira J, Kucharska E, Budni J, Kim Y . The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease. Life Sci. 2020; 257:118020. DOI: 10.1016/j.lfs.2020.118020. View

Amiri S, Jafari-Sabet M, Keyhanfar F, Falak R, Shabani M, Rezayof A . Hippocampal and prefrontal cortical NMDA receptors mediate the interactive effects of olanzapine and lithium in memory retention in rats: the involvement of CAMKII-CREB signaling pathways. Psychopharmacology (Berl). 2020; 237(5):1383-1396. DOI: 10.1007/s00213-020-05465-4. View

Aranarochana A, Chaisawang P, Sirichoat A, Pannangrong W, Wigmore P, Welbat J . Protective effects of melatonin against valproic acid-induced memory impairments and reductions in adult rat hippocampal neurogenesis. Neuroscience. 2019; 406:580-593. DOI: 10.1016/j.neuroscience.2019.02.022. View

Aranarochana A, Kaewngam S, Anosri T, Sirichoat A, Pannangrong W, Wigmore P . Hesperidin Reduces Memory Impairment Associated with Adult Rat Hippocampal Neurogenesis Triggered by Valproic Acid. Nutrients. 2021; 13(12). PMC: 8708262. DOI: 10.3390/nu13124364. View

Barichello T, Ceretta R, Generoso J, Moreira A, Simoes L, Comim C . Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis. Eur J Pharmacol. 2012; 697(1-3):158-64. DOI: 10.1016/j.ejphar.2012.09.053. View

Bast T, Pezze M, McGarrity S . Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition. Br J Pharmacol. 2017; 174(19):3211-3225. PMC: 5595754. DOI: 10.1111/bph.13850. View

Bloomfield M, Green S, Hindocha C, Yamamori Y, Yim J, Jones A . The effects of acute cannabidiol on cerebral blood flow and its relationship to memory: An arterial spin labelling magnetic resonance imaging study. J Psychopharmacol. 2020; 34(9):981-989. PMC: 7436497. DOI: 10.1177/0269881120936419. View

Burstein S . Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. Bioorg Med Chem. 2015; 23(7):1377-85. DOI: 10.1016/j.bmc.2015.01.059. View

10.

Cabral-Pereira G, Sanchez-Benito D, Diaz-Rodriguez S, Goncalves J, Sancho C, Castellano O . Behavioral and Molecular Effects Induced by Cannabidiol and Valproate Administration in the GASH/Sal Model of Acute Audiogenic Seizures. Front Behav Neurosci. 2021; 14:612624. PMC: 7862126. DOI: 10.3389/fnbeh.2020.612624. View

11.

Campos A, Fogaca M, Sonego A, Guimaraes F . Cannabidiol, neuroprotection and neuropsychiatric disorders. Pharmacol Res. 2016; 112:119-127. DOI: 10.1016/j.phrs.2016.01.033. View

12.

Cassol Jr O, Comim C, Silva B, Hermani F, Constantino L, Felisberto F . Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture. Brain Res. 2010; 1348:128-38. DOI: 10.1016/j.brainres.2010.06.023. View

13.

Cheng D, Spiro A, Jenner A, Garner B, Karl T . Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice. J Alzheimers Dis. 2014; 42(4):1383-96. DOI: 10.3233/JAD-140921. View

14.

Devinsky O, Cilio M, Cross H, Fernandez-Ruiz J, French J, Hill C . Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia. 2014; 55(6):791-802. PMC: 4707667. DOI: 10.1111/epi.12631. View

15.

Eivani M, Alijanpour S, Arefian E, Rezayof A . Corticolimbic analysis of microRNAs and protein expressions in scopolamine-induced memory loss under stress. Neurobiol Learn Mem. 2019; 164:107065. DOI: 10.1016/j.nlm.2019.107065. View

16.

Fagherazzi E, Garcia V, Maurmann N, Bervanger T, Halmenschlager L, Busato S . Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders. Psychopharmacology (Berl). 2011; 219(4):1133-40. DOI: 10.1007/s00213-011-2449-3. View

17.

Fisher R, Acevedo C, Arzimanoglou A, Bogacz A, Cross J, Elger C . ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014; 55(4):475-82. DOI: 10.1111/epi.12550. View

18.

Godsil B, Kiss J, Spedding M, Jay T . The hippocampal-prefrontal pathway: the weak link in psychiatric disorders?. Eur Neuropsychopharmacol. 2013; 23(10):1165-81. DOI: 10.1016/j.euroneuro.2012.10.018. View

19.

Hasselmo M . The role of acetylcholine in learning and memory. Curr Opin Neurobiol. 2006; 16(6):710-5. PMC: 2659740. DOI: 10.1016/j.conb.2006.09.002. View

20.

HIRONAKA N, Tanaka K, Izaki Y, Hori K, Nomura M . Memory-related acetylcholine efflux from rat prefrontal cortex and hippocampus: a microdialysis study. Brain Res. 2001; 901(1-2):143-50. DOI: 10.1016/s0006-8993(01)02338-1. View